“Hard to Reach” Is a Sponsor Operations Failure, Not a Population Problem
The Lancet calls out "hard to reach" as a stigmatizing label. For clinical ops, it's a site selection failure...
Diversity Recruitment Operations
Your GBA1 Enrollment Plan Is Built for European Sites — And That’s a Problem
Lancet Neurology data shows <4% of Parkinson's genetic trials enroll non-European patients. Here's what ops teams must fix before...